RHYTHMIA
Total Payments
$3.3M
Transactions
6,964
Doctors
1,633
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $173,741 | 1,004 | 392 |
| 2020 | $397,369 | 814 | 284 |
| 2019 | $923,743 | 1,944 | 721 |
| 2018 | $1.3M | 1,964 | 740 |
| 2017 | $490,056 | 1,238 | 477 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.7M | 34 | 50.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $533,355 | 682 | 16.3% |
| Consulting Fee | $508,706 | 57 | 15.5% |
| Food and Beverage | $287,380 | 5,263 | 8.8% |
| Travel and Lodging | $286,552 | 917 | 8.8% |
| Grant | $3,988 | 2 | 0.1% |
| Education | $1,432 | 9 | 0.0% |
Payments by Type
Research
$1.7M
34 transactions
General
$1.6M
6,930 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| DECAAF II | Boston Scientific Corporation | $653,918 | 0 |
| CABANA | Boston Scientific Corporation | $500,000 | 0 |
| DECAAF II | BOSTON SCIENTIFIC CORPORATION | $245,340 | 0 |
| Electrogram analysis for AFib substrate characterization | Boston Scientific Corporation | $45,000 | 0 |
| DREAM | Boston Scientific Corporation | $44,172 | 0 |
| PANACEA | Boston Scientific Corporation | $32,000 | 0 |
| Ventricular Tachycardia Ablation in Patients with Coronary Disease Functionalguided Substrate Ablation | Boston Scientific Corporation | $28,000 | 0 |
| Propagation Analysis for Arrhymthmogenic Conduction Elimination to Prevent Atrial Flutter and Fibrillation Panacea AF | Boston Scientific Corporation | $25,000 | 0 |
| Ventricular Tachycardia Ablation in Patients with Coronary Disease Functional guided Substrate Ablation | Boston Scientific Corporation | $24,000 | 0 |
| RHAPSODY | BOSTON SCIENTIFIC CORPORATION | $23,705 | 0 |
| Cryoballoon vs Rhythmia Guided RF Ablation for Redo PVI | Boston Scientific Corporation | $15,000 | 0 |
| RHAPSODY | Boston Scientific Corporation | $14,125 | 0 |
Top Doctors Receiving Payments for RHYTHMIA
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Royal Oak, MI | $2.1M | 61 |
| , MD | Clinical Cardiac Electrophysiology | Lutz, FL | $58,761 | 61 |
| , MD | Cardiovascular Disease | Boise, ID | $51,992 | 62 |
| , M.D | Internal Medicine | Chapel Hill, NC | $40,870 | 62 |
| , M.D | Clinical Cardiac Electrophysiology | Boston, MA | $38,240 | 23 |
| , M.D | Internal Medicine | Houston, TX | $36,303 | 161 |
| , M.D | Cardiovascular Disease | Tyler, TX | $33,635 | 110 |
| , MD | Cardiovascular Disease | Tyler, TX | $29,819 | 107 |
| , MD | Clinical Cardiac Electrophysiology | Manchester, NH | $29,404 | 19 |
| , M.D | Internal Medicine | Lincoln, NE | $25,050 | 60 |
| , M.D | Clinical Cardiac Electrophysiology | Burlington, MA | $23,737 | 36 |
| , M.D | Specialist | Springfield, IL | $22,199 | 35 |
| , MD | Cardiovascular Disease | Oklahoma City, OK | $21,648 | 24 |
| , MD | Clinical Cardiac Electrophysiology | West Des Moines, IA | $20,263 | 39 |
| , M.D | Pediatric Hematology-Oncology | Mountain View, CA | $16,500 | 1 |
| Hugh Mcelderry | Clinical Cardiac Electrophysiology | Birmingham, AL | $16,299 | 15 |
| , MD | Cardiovascular Disease | Boise, ID | $15,496 | 23 |
| , M.D | Cardiovascular Disease | Birmingham, AL | $12,310 | 13 |
| , M.D | Cardiovascular Disease | Cincinnati, OH | $11,562 | 26 |
| , M.D | Clinical Cardiac Electrophysiology | Newport Beach, CA | $11,438 | 17 |
| , MD | Cardiovascular Disease | Norristown, PA | $11,364 | 35 |
| , M.D | Cardiovascular Disease | Paoli, PA | $10,520 | 58 |
| , MD | Internal Medicine | Tyler, TX | $10,268 | 35 |
| , M.D., PH.D | Internal Medicine | Bedford, TX | $9,128 | 52 |
| , M.D | Clinical Cardiac Electrophysiology | New York, NY | $8,796 | 16 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $3.3M
- Total Doctors 1,633
- Transactions 6,964
About RHYTHMIA
RHYTHMIA is a device associated with $3.3M in payments to 1,633 healthcare providers, recorded across 6,964 transactions in the CMS Open Payments database. The primary manufacturer is BOSTON SCIENTIFIC CORPORATION.
Payment data is available from 2017 to 2021. In 2021, $173,741 was paid across 1,004 transactions to 392 doctors.
The most common payment nature for RHYTHMIA is "Unspecified" ($1.7M, 50.4% of total).
RHYTHMIA is associated with 12 research studies, including "DECAAF II" ($653,918).